Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.56 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.46 |
| ▸ | KDM4A | O75164 | 2/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.46 |
| ▸ | TET3 | O43151 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.42 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Desmeninol SCHEMBL9331726 | 0.98 | — | — | |
| Desmeninol SCHEMBL167046 | 0.98 | — | — | |
| Desmeninol SCHEMBL3346262 | 0.98 | — | — | |
| Desmeninol SCHEMBL1685417 | 0.95 | RNPEP (0.56) | RNPEPTET2KDM4AKDM4CKDM2A | |
| Desmeninol SCHEMBL4818040 | 0.95 | RNPEP (0.56) | RNPEPTET2KDM4AKDM4CKDM2A | |
| Desmeninol SCHEMBL28041403 | 0.95 | RNPEP (0.56) | RNPEPTET2KDM4AKDM4CKDM2A | |
| Desmeninol SCHEMBL986705 | 0.95 | RNPEP (0.56) | RNPEPTET2KDM4AKDM4CKDM2A | |
| Desmeninol SCHEMBL1685412 | 0.95 | RNPEP (0.56) | RNPEPTET2KDM4AKDM4CKDM2A | |
| Desmeninol SCHEMBL28980028 | 0.95 | RNPEP (0.56) | RNPEPTET2KDM4AKDM4CKDM2A | |
| Desmeninol SCHEMBL27801434 | 0.95 | RNPEP (0.56) | RNPEPTET2KDM4AKDM4CKDM2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101891660-A | Method for preparing 2-hydroxy-4-methylmercapto copper butyrate | TIANJIN CHEM REAGENT RES INST | 2010-11-24 | — | — | CN | claimed |
| CN-101287805-B | Marine antifouling coating compositions | NOVUS INT INC | 2011-11-02 | — | — | CN | disclosed |
| CN-101891660-A | Method for preparing 2-hydroxy-4-methylmercapto copper butyrate | TIANJIN CHEM REAGENT RES INST | 2010-11-24 | — | — | CN | disclosed |
| CN-101287698-A | Canned and dry-coated antimicrobial compositions containing hydroxy analogs and derivatives of methionine | NOVUS INT INC (US) | 2008-10-15 | — | — | CN | disclosed |
| CN-101287805-A | Marine antifouling coating compositions | NOVUS INT INC (US) | 2008-10-15 | — | — | CN | disclosed |
| EP-1922372-A2 | MARINE ANTIFOULING COATING COMPOSITIONS | Novus International, Inc. (US) | 2008-05-21 | — | — | EP | disclosed |
| US-7335248-B2 | Marine antifouling coating compositions | NOVUS INTERNATIONAL, INC. (US) | 2008-02-26 | — | — | US | disclosed |
| US-20070213426-A1 | MARINE ANTIFOULING COATING COMPOSITIONS | NOVUS INTERNATIONAL INC. (US) | 2007-09-13 | — | — | US | disclosed |
| WO-2007030409-A2 | IN-CAN AND DRY COATING ANTIMICROBIAL COMPOSITIONS HAVING HYDROXY ANALOGS OF METHIONINE AND DERIVATIVES | NOVUS INTERNATIONAL INC. (US) | 2007-03-15 | — | — | WO | disclosed |
| WO-2007030389-A2 | MARINE ANTIFOULING COATING COMPOSITIONS | NOVUS INTERNATIONAL INC. (US) | 2007-03-15 | — | — | WO | disclosed |
| US-20070053866-A1 | IN-CAN AND DRY COATING ANTIMICROBIAL COMPOSITIONS HAVING HYDROXY ANALOGS OF METHIONINE AND DERIVATIVES | NOVUS INTERNATIONAL INC. (US) | 2007-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070053866-A1 | IN-CAN AND DRY COATING ANTIMICROBIAL COMPOSITIONS HAVING HYDROXY ANALOGS OF METHIONINE AND DERIVATIVES | BHMT2, INMT, AHCY | RNPEP 1680/4885TET2 89/4885KDM4A 1106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.